TALK KEYWORD INDEX
This page contains an index consisting of author-provided keywords.
| 1 | |
| 16S rRNA gene sequencing | |
| 2 | |
| 2x2 | |
| 4 | |
| 4pLL model | |
| A | |
| Aalen-Johansen estimator | |
| Abdominal aortic aneurysms | |
| Accelerometers | |
| accuracy | |
| Acinetobacter baumannii | |
| acoustic feature | |
| action threshold | |
| adaptive design | |
| adaptive enrichment design | |
| adaptive Gauss-Hermite quadrature | |
| Adaptive randomisation | |
| Adaptive randomization | |
| adaptive threshold design | |
| adaptive trial design | |
| Additional Benefit Assessment | |
| additive predictor | |
| administrative data | |
| adolescents | |
| adverse drug events | |
| adverse drug reactions | |
| adverse events | |
| agent-based model | |
| agent-based modelling | |
| aging | |
| AI | |
| Air pollutants | |
| Alternating recurrent events | |
| Alzheimer’s disease | |
| Amyotrophic Lateral Sclerosis | |
| Analysis | |
| analysis population | |
| ANCOVA | |
| anemia | |
| animal experiment | |
| Annealed variational inference | |
| ANOVA | |
| antibiotic resistance | |
| anxiety | |
| Applicability | |
| Approximate Bayesian computation (ABC) | |
| Artificial intelligence | |
| Artificial Neuron | |
| assay sensitivity | |
| Association parameter | |
| Association structure | |
| AUC | |
| awake thoracic surgery | |
| B | |
| Background mortality | |
| baseline imbalance | |
| basket trial | |
| Basket trial design | |
| basket trials | |
| bayes factor | |
| Bayesian | |
| Bayesian analysis | |
| Bayesian approach | |
| Bayesian clinical trial design | |
| Bayesian clinical trials design | |
| bayesian data assimilation | |
| Bayesian decision-theory | |
| Bayesian disease mapping | |
| Bayesian Factor Analysis for interaction (FIN) | |
| Bayesian hierarchical model | |
| Bayesian hierarchical modeling | |
| Bayesian inference | |
| Bayesian joint modeling | |
| Bayesian Latent Class Analysis | |
| Bayesian methods | |
| bayesian model averaging | |
| Bayesian modelling | |
| Bayesian models | |
| bayesian optimal interval design | |
| Bayesian P-splines | |
| Bayesian Posterior Probabilities | |
| Bayesian regression | |
| Bayesian statistics | |
| Bayesian variable selection | |
| baymedr | |
| Benchmark | |
| Besag York Mollié (BYM) | |
| between-individual variance | |
| bias | |
| Bias (epidemiology) | |
| Bias quantification | |
| bias-variance trade-off | |
| big data | |
| binary classification | |
| binary outcome | |
| Binary outcomes | |
| Bioequivalence | |
| biomarker | |
| biomarker trajectory | |
| Biomarker-strategy | |
| Biomarkers | |
| birth cohorts | |
| Birth interval | |
| Bivariate toxicity | |
| BKMR | |
| bladder cancer | |
| Blood pressure variability | |
| Blood test | |
| BMI | |
| Bootstrap | |
| borrowing from external data | |
| bounds | |
| Breast cancer | |
| Bullous pemphigoid | |
| C | |
| Calibration | |
| Calibration slope | |
| Cancer | |
| Cancer clinical trial | |
| cancer regression | |
| cancer screening | |
| Cardiomyopathy | |
| Cardiovascular | |
| Cardiovascular disease | |
| Cardiovascular risk | |
| Case control | |
| case-cohort study | |
| Case-control designs | |
| Case-control studies | |
| causal effect | |
| Causal effect direction | |
| Causal effect generalization | |
| Causal Graph | |
| Causal inference | |
| Causal mediation analysis | |
| Causality | |
| Censoring | |
| change | |
| Charlson Comorbidity Index | |
| childhood cancer | |
| choroid plexus | |
| Chronic diseases | |
| Chronological bias | |
| circular data | |
| Classification | |
| classifiers | |
| clinical | |
| clinical decision making | |
| Clinical phase III trials | |
| Clinical practice research datalink | |
| Clinical prediction | |
| Clinical prediction models | |
| clinical risk score | |
| clinical trial | |
| clinical trial analysis | |
| clinical trial analysis plans | |
| clinical trial design | |
| Clinical trial innovation | |
| clinical trial reporting | |
| Clinical trials | |
| Cluster | |
| Cluster Analysis | |
| cluster level analysis | |
| cluster randomisation | |
| cluster randomised trial | |
| cluster randomised trials | |
| cluster randomized Intervention | |
| cluster randomized trials | |
| cluster stepped wedge | |
| cluster-randomised trial | |
| Clustered data | |
| clustered time-to-event data | |
| Clustering | |
| Cochrane | |
| Cochrane Database of Systematic Reviews | |
| Coefficient of determination | |
| cognitive bias | |
| Cohort design | |
| cohort study | |
| cohorting | |
| collapsibility | |
| collider bias | |
| colorectal cancer | |
| combination therapy | |
| Comorbidities | |
| comorbidity | |
| comparison study | |
| Compartmental model | |
| Competing risk | |
| Competing risks | |
| competitive risk | |
| Complex interventions | |
| composite endpoint | |
| computer-aided diagnosis | |
| Concordance | |
| concordance discordance model | |
| Concurrent controls | |
| conditional autoregressive (CAR) models | |
| Confidence Band | |
| Confidence Interval | |
| confidence interval estimation | |
| Confirmatory factor analysis | |
| Confounding Bias | |
| Congeniality | |
| congenital anomalies | |
| consensus building | |
| Constrained randomisation | |
| contact tracing | |
| Continuous monitoring | |
| correlated data | |
| Correlated test statistics | |
| correlation | |
| count data | |
| Counterfactual | |
| counterfactual prediction | |
| Covariate measurement | |
| covariate selection | |
| covariates | |
| COVID | |
| Covid 19 | |
| COVID-19 | |
| COVID-19 patients | |
| covid19 | |
| Cox proportional hazard model | |
| Cox proportional-hazards regression | |
| Critical care | |
| Critical Community Size | |
| Cross-classified data | |
| Cross-contamination | |
| Cumulative incidence functions | |
| cumulative link model | |
| Cumulative probability of toxicity | |
| Cure models | |
| cut-point | |
| CV risk factors | |
| Cystic Fibrosis | |
| Czech National Cancer Registry | |
| D | |
| Data aggregation | |
| Data integration | |
| data linkage | |
| Data quality | |
| Data Set Size | |
| data sharing | |
| Data validation | |
| Data visualisation | |
| decision curve analysis | |
| decision making | |
| Decision-making | |
| deep generative models | |
| deep learning | |
| Deep neural network | |
| DeepNLME | |
| deft interaction | |
| Delay in reporting | |
| delayed treatment effect | |
| Dementia | |
| dense longitudinal data | |
| dentistry | |
| Dependent censoring | |
| depression | |
| Depth Measures | |
| Design-based inference | |
| Determinants of Health | |
| Device | |
| Diabetes Mellitus | |
| diabetic nephropathy | |
| diagnosis | |
| diagnostic accuracy | |
| Diagnostic performance | |
| diagnostic test | |
| Diagnostic test accuracy | |
| Diagnostic test evaluation | |
| Diagnostic tests | |
| DIC | |
| differentiable programming | |
| differential equations | |
| Dimensionality reduction | |
| direct and indirect effects | |
| disability | |
| discrete random effect | |
| Disease history | |
| Disease mapping | |
| Disease progression | |
| Disruption | |
| distributional regression | |
| Distributional shift | |
| Diuretics | |
| diversity measures | |
| Dose-finding | |
| Dose-finding study | |
| Dose-regimen | |
| dose-response | |
| Dose-response curves | |
| dose-response model | |
| dosimetry | |
| Double robustness | |
| double selection | |
| doubly interval-censored | |
| Down syndrome | |
| Dropout | |
| Drug benefit-risk | |
| drug development | |
| Drug regulation | |
| Drug-Related Side Effects and Adverse Reactions | |
| Dynamic AUC | |
| Dynamic Brier Score | |
| Dynamic modelling | |
| dynamic models | |
| Dynamic prediction | |
| Dynamic predictions | |
| dynamic structural equation modeling | |
| dynamic treatment regimens | |
| dynamical systems | |
| dysbiosis | |
| E | |
| early completion | |
| Early phase oncology | |
| Early-phase clinical trial | |
| Ebola virus disease sequelae | |
| ECG | |
| ECM algorithm | |
| EEG Channel Selection | |
| EEG Signal Processing | |
| effect decomposition | |
| effectiveness | |
| efficient influence curve | |
| Elderly | |
| Electronic health record | |
| electronic health records | |
| Electronic healthcare records | |
| Elicitation | |
| EM-algorithm | |
| Empirical Bayes | |
| empirical Bayes estimator | |
| Endometriosis | |
| endpoint selection | |
| endpoints | |
| enrichment designs | |
| ensemble machine learning | |
| Environmental exposure | |
| Epidemic Modeling | |
| epidemic modelling | |
| epidemic monitoring | |
| Epidemic renewal equation | |
| Epidemiological biases | |
| Epidemiological model | |
| Epidemiology | |
| Epidemiology methods | |
| Epigenetic annotations | |
| epigenetics | |
| equivalence | |
| equivalence test | |
| error model | |
| error rate | |
| Estimand | |
| Estimation bias | |
| Ethics | |
| evaluation | |
| Evidence synthesis | |
| exact test | |
| Exaggeration | |
| excess hazard | |
| excess hazard model | |
| Excess mortality | |
| expected squared prediction error | |
| expedited approval | |
| experimental design | |
| Experts’ elicitation | |
| Explained variation | |
| exposomics | |
| extended Kalman filter | |
| external data | |
| External validation | |
| external validity | |
| extra non-cancer mortality | |
| extrapolation | |
| F | |
| face | |
| facial palsy | |
| Factor analysis | |
| factorial design | |
| False Discovery Rate | |
| familywise error rate | |
| FDA | |
| feature extraction | |
| feature selection | |
| Features Selection | |
| Fine-Gray model | |
| finite-population correction | |
| first type error rate | |
| Firth’s correction | |
| flexible modeling | |
| flexible parametric models | |
| Flexible Parametric Survival Model | |
| Flipped Classroom | |
| Flow of evidence | |
| forecast | |
| fractional polynomials | |
| frailty | |
| frailty model | |
| Framingham Heart Study | |
| frequentist | |
| frequentist operating characteristics | |
| Full blood count | |
| Full Information Maximum Likelihood | |
| full matching | |
| Functional concurrent regression | |
| functional data analysis | |
| G | |
| g-computation | |
| Gaussian process | |
| GBM | |
| Gene expression | |
| generalised Dirichlet distribution | |
| generalised estimating equations | |
| generalised linear mixed model | |
| Generalised linear mixed models | |
| generalizability | |
| generalized estimating equations | |
| generalized functional linear model | |
| Generalized gamma distribution | |
| Generalized Linear Mixed Model (GLMM) | |
| Generalized linear models | |
| generalized pairwise comparisons | |
| Generalized propensity score | |
| Genome wide association study | |
| Geometric Brownian motion | |
| Gini index | |
| GLM | |
| Go/No-Go | |
| gold-standard | |
| Gompertz model | |
| gonorrhea | |
| Goodness of Fit (GOF) | |
| Goodness-of-fit | |
| Granularity | |
| Graph-theory | |
| Group sequential Holm | |
| Group sequential tests | |
| grouped | |
| growth curves | |
| Guidelines | |
| H | |
| Hamiltonian Monte Carlo inference | |
| Haplotype reconstruction | |
| Hazard ratio | |
| Health Data Science | |
| health insurance | |
| Health-related quality of life | |
| healthcare worker screening | |
| healthy controls | |
| Hematology | |
| Hemoadsorption | |
| Hepatitis C | |
| Heritability | |
| heterogeneity | |
| Heteroscedasticity | |
| hidden markov model | |
| hierarchical | |
| hierarchical clustering | |
| Hierarchical data | |
| hierarchical endpoints | |
| Hierarchical sparse regression modelling | |
| hierarchical testing | |
| High-Dimensional Data | |
| high-dimensional dataset | |
| highly adaptive lasso | |
| Historic Controls | |
| Historical borrowing | |
| Historical controls | |
| Historical Data | |
| historical data borrowing | |
| Historical information | |
| HIV | |
| HIV biomarkers | |
| HIV/AIDS | |
| Hong Kong | |
| Hospital epidemiology | |
| hospital readmissions | |
| Human Papillomavirus | |
| hyperopia | |
| Hypertension | |
| hypothesis test | |
| Hypothesis tests | |
| Hypothetical strategy | |
| I | |
| iatrogenic complications | |
| ICU trials | |
| Identification | |
| IgA nephropathy | |
| Immortal time bias | |
| Immortal-time bias | |
| Immuno-oncology | |
| immunotherapy trial | |
| imperfect gold | |
| imputation | |
| In-hospital mortality | |
| Incidence | |
| Incidence density sampling | |
| Incident-user design | |
| Inconsistency | |
| incubation time | |
| India | |
| Indirect evidence | |
| individual differences | |
| Individual participant data | |
| Individual Participant Data Meta-Analysis | |
| Individual prediction | |
| individual-based modelling | |
| individualized prediction models | |
| Individualized predictions | |
| inequality | |
| Infant mortality | |
| infection fatality rate | |
| Infectious Disease | |
| Infectious Diseases | |
| influential points | |
| information anchoring | |
| information sharing | |
| information theory | |
| informative visit | |
| Innovative interpretation methods | |
| Innovative methods | |
| Instrumental variables | |
| inteference | |
| intensive longitudinal data | |
| Interaction | |
| Interactions | |
| interactive | |
| Interactive graphics | |
| Interim analysis | |
| International Classification of Diseases | |
| Interoperability | |
| interpretability | |
| Interrupted time series | |
| Interval sampling | |
| interval-censored data | |
| Intervention studies | |
| interventional effects | |
| Inverse probability of treatment weighting | |
| Inverse probability weighting | |
| IPD meta-analysis | |
| IPTW | |
| isolation | |
| Item Response Theory | |
| J | |
| jack-knife | |
| Joint model | |
| Joint modeling | |
| Joint modelling | |
| Joint modelling for longitudinal and survival data | |
| joint models | |
| Joint models for time to event and longitudinal data | |
| K | |
| Kaplan-Meier test | |
| kernel density estimation | |
| Kidney function | |
| KIR | |
| Klebsiella pneumoniae | |
| knee society score | |
| Kullback-Leibler divergence | |
| L | |
| lab tests | |
| Landmark | |
| Landmark analysis | |
| Landmark approach | |
| Landmark modeling | |
| Landmarking | |
| Laplace approximations | |
| Lasso | |
| Last observation carried forward | |
| Late-onset toxicity | |
| Latency | |
| latency time | |
| latent class | |
| Latent class growth models | |
| latent class model | |
| Latent Markov models | |
| latent variable | |
| Latent variable method | |
| Latent Variable Models | |
| latent variable models with interaction | |
| lead-time | |
| Learning Curve | |
| Left truncation | |
| left-truncation | |
| Length of stay | |
| Length-biased Sampling | |
| life expectancy | |
| Life table | |
| life years lost | |
| lifestyle modification | |
| Lifetables | |
| likelihood penalization | |
| lineage | |
| linear combination | |
| Linear mixed effects model | |
| Linear mixed model | |
| Linear mixed models | |
| Linear mixed-effects models | |
| linear regression models | |
| Linearity assumptions | |
| link function | |
| Liver allocation | |
| LMPL | |
| Local incidence | |
| Lockdown | |
| Log-rank test | |
| Logistic regression | |
| longitudinal | |
| longitudinal cluster randomized trials | |
| longitudinal covariates | |
| Longitudinal data | |
| Longitudinal data analysis | |
| Longitudinal growth model | |
| Longitudinal outcome | |
| longtudinal models | |
| Low outcome rate | |
| Lower Limit of Quantification | |
| lung cancer | |
| M | |
| MACE | |
| machine learning | |
| Machine learning methods | |
| Machine Learning models | |
| mammography screening | |
| mapping | |
| marginal and conditional effects | |
| Marginal structural models | |
| Marginality principle | |
| Marginalized Two-part Joint Model | |
| Martingale theory | |
| Master Protocol | |
| Matching | |
| maximally selected statistics | |
| Maximum Likelihood Method | |
| MCP-Mod | |
| Mean Residual Life | |
| Mean squared error | |
| Mean Survival Time | |
| measure of separation | |
| Measurement error | |
| Mecanistic modelling | |
| MedDRA | |
| medians | |
| Mediation | |
| mediation analysis | |
| Medication effect | |
| Mendelian Randomization | |
| meta-analysis | |
| Meta-analytic-predictive (MAP) | |
| Meta-analytic-predictive prior | |
| Meta-research | |
| Metabolic syndrome | |
| Metagenomic analysis of the gut microbiota | |
| Method(s) Validation and/or Comparison | |
| Methodological development | |
| methodological review | |
| Methodology | |
| Methods comparison | |
| mHealth | |
| MICE | |
| micro-randomized trial | |
| Microbiome | |
| minimal clinically important difference | |
| minimal data | |
| Misclassification | |
| misclassification costs | |
| misfolded protein tau | |
| missing | |
| Missing data | |
| missing evidence | |
| Missing indicator | |
| Missing not at Random | |
| missing outcome data | |
| Missing Values | |
| mixed | |
| mixed censoring | |
| Mixed effects location scale models | |
| Mixed effects modelling | |
| mixed model | |
| Mixed models | |
| mixture cure models | |
| Mixture effect | |
| mixture models | |
| mobile health | |
| model | |
| model averaging | |
| Model for End-stage Liver Disease (MELD) | |
| Model misspecification | |
| Model selection | |
| Model Sensitivity | |
| Model-based analysis | |
| Model-Based Clustering | |
| modeling | |
| Modelling | |
| Models | |
| modular | |
| Molecular quantitative trait locus studies | |
| monitoring | |
| Monte Carlo simulation | |
| Monte-Carlo simulation | |
| Mortality | |
| MOVER | |
| Multi-armed bandits | |
| Multi-criteria decision analysis | |
| multi-item scale | |
| multi-omics data | |
| Multi-response model | |
| Multi-state model | |
| Multi-state modelling | |
| multi-state models | |
| Multi-task learning | |
| Multidimensional mediators | |
| Multidrug Resistance | |
| multifactorial intervention | |
| multilevel | |
| Multilevel data | |
| multilevel modelling | |
| multilevel models | |
| multimorbidity | |
| Multiple Cox regression analysis | |
| multiple imputation | |
| multiple mediation analysis | |
| Multiple outcomes | |
| Multiple primary hypotheses | |
| multiple sclerosis | |
| multiple testing | |
| multiple tests | |
| multiple thresholds | |
| multiple time points | |
| multiple time-point interventions | |
| multiplicity correction | |
| multistate model | |
| Multistate models | |
| Multivariable | |
| multivariable analysis | |
| multivariable model-building | |
| Multivariate data | |
| Multivariate longitudinal data | |
| Multivariate markers | |
| Multivariate meta-analysis | |
| multivariate Student-t distribution | |
| mutant | |
| N | |
| national clinical datasets | |
| Natural Language Processing | |
| Negative control outcomes | |
| Negative Predictive Value | |
| neonates | |
| nephrology | |
| Nested case-control design | |
| net benefit | |
| Net survival | |
| network | |
| network analysis | |
| Network meta-analysis | |
| network meta-regression | |
| neural differential equations | |
| Neural Networks | |
| neurodegenerative disease | |
| Neurodegenerative Diseases | |
| Next generation sequencing | |
| NGS | |
| non-adherance | |
| Non-compartmental analysis | |
| non-convex optimization | |
| non-homogenuous Poisson model | |
| non-ignorable | |
| non-inferiority | |
| non-inferiority trials | |
| non-intubated lung resection | |
| non-intubated VATS lobectomy | |
| non-linear mixed effects model | |
| non-normal random effect | |
| Non-proportional hazards | |
| Non-Small-Cell Lung Carcinoma | |
| non-stationarity | |
| Nonlinear mixed effects models | |
| Nonlinear mixed models | |
| nonparametric | |
| nonparametric Bayesian methods | |
| Nonparametric methods | |
| North Rhine-Westphalia | |
| nosocomial transmission | |
| nowcast | |
| O | |
| O2PLS | |
| observational data | |
| Observational evidence | |
| observational studies | |
| Observational study | |
| obstructive sleep apnea | |
| ODE-based models | |
| Omics | |
| Omics integration | |
| oncology | |
| Oncology trials | |
| open cohort | |
| opioids | |
| optimal design | |
| optimum dose | |
| Oral prednisolone | |
| ordered probit model | |
| ordinal | |
| ordinal data | |
| ordinal endpoints | |
| ordinal outcome | |
| ordinal regression | |
| Ordinary Differential Equations | |
| osteoarthritis | |
| Osteosarcoma | |
| outcome measurement | |
| Overrunning | |
| P | |
| P-values | |
| Paediatric ophthalmology | |
| Pain management | |
| Pain Therapy | |
| paired data design | |
| Pandemic curve flattening | |
| Parametric inference | |
| Partly conditional transition rate | |
| path analysis | |
| pathological voice | |
| Patient allocation | |
| patient identifiers | |
| Patient preference | |
| patient-level covariate | |
| patient-reported outcome | |
| patients' heterogeneity | |
| PCA | |
| pediatric cancer | |
| Pediatrics | |
| Penalised generalised linear models | |
| penalized likelihood | |
| penalized log-likelihood | |
| Penalized logistic regression | |
| Penalized natural spline | |
| Perfect Tree | |
| Performance | |
| Performance measures | |
| personal protective equipment | |
| Personalised Medicine | |
| personalized medicine | |
| personalized prediction models | |
| Personalized randomisation | |
| PET/CT medical imaging | |
| Pharmaco-epidemiology | |
| Pharmacoepidemiology | |
| Pharmacokinetics | |
| Pharmacokinetics/pharmacodynamics | |
| pharmacometrics | |
| pharmacovigilance | |
| phase I cancer clinical trials | |
| phase II trials | |
| phenomenological models | |
| Physical activity | |
| Physical education | |
| platform trial | |
| Platform trial design | |
| Platform trials | |
| PLS-DA | |
| Pneumonia | |
| Poincare plots | |
| point estimation | |
| Poisson Distribution | |
| Poisson Model | |
| Polygenic risk | |
| Polygenic risk scores | |
| polynomial trend | |
| Pompe disease | |
| Population Attributable Fraction | |
| population based | |
| population based cancer registry | |
| population finding | |
| population-based cohort study | |
| Positive Predictive Value | |
| Post-selection inference | |
| Post-test Predictive Probability | |
| post-treatment score | |
| potential survival | |
| power | |
| Power calculation | |
| Power prior | |
| pragmatic trials | |
| Pre-hospital Care | |
| Pre-test Predictive Probability | |
| Precision medicine | |
| precision oncology | |
| Precision/personalized medicine | |
| Preclinical to human extrapolation | |
| prediction | |
| Prediction accuracy | |
| Prediction model | |
| Prediction Models | |
| predictive modeling | |
| Predictive modelling | |
| predictive models | |
| Predictive performance | |
| Predictive probability of success | |
| predictive values | |
| Preference-based health measure | |
| Prescription-based drug exposure | |
| preterm infant | |
| Prevalent Cohort | |
| Prevalent-user design | |
| principal stratification | |
| Prior distributions | |
| Prior information | |
| Prior-data conflict | |
| prioritized outcomes | |
| Probabilistic data integration | |
| probabilistic linkage | |
| Probability estimation | |
| Probability machine | |
| Probiotics | |
| probit link | |
| prognistic index evaluation | |
| prognosis | |
| Prognostic factors | |
| Prognostic model | |
| Projection-based estimation | |
| Propensity score | |
| propensity score matching | |
| Propensity scores | |
| proportional hazards assumption | |
| Proportional Hazards Models | |
| Proportional hazards regression | |
| proportional odds model | |
| Prospective study | |
| Prostate cancer | |
| pseudo individual participant data | |
| pseudo-observations | |
| Pseudomonas aeruginosa | |
| psychiatry | |
| public health | |
| Public health modelling | |
| Pulmonary Exacerbation | |
| Q | |
| Quality control | |
| quality of life | |
| quantile regression | |
| Quantitative exposure | |
| Quarantine | |
| questionnaires | |
| R | |
| R implementation | |
| R package | |
| Radiomics | |
| Random coefficients approach | |
| random effect models | |
| random effects | |
| random forest | |
| Random Forests | |
| Random slopes models | |
| Random Survival Forest | |
| Random walks | |
| randomised control trials | |
| Randomised controlled trial | |
| randomised controlled trials | |
| Randomization | |
| randomization inference | |
| randomized | |
| Randomized Clinical Trials | |
| randomized controlled trial | |
| Randomized controlled trials | |
| randomized experiments | |
| Ranking | |
| Rapid review | |
| Rare disease | |
| rare diseases | |
| Ratios | |
| RCT | |
| RCTs | |
| Re-analysis | |
| Real world data | |
| real world evidence | |
| Real-world data | |
| Real-World evidence | |
| record linkage | |
| Recurrent events | |
| recurrent events duration | |
| Recurrent-event-models | |
| Registries | |
| Registry analysis | |
| registry data | |
| registry-based data | |
| registry-based studies | |
| registry-based study | |
| regression | |
| regression analysis | |
| Regression calibration | |
| Regression models | |
| regression splines | |
| Reinke’s edema | |
| Relative survival | |
| repeated measures | |
| reporting | |
| reporting bias | |
| reporting delay | |
| Reporting guidelines | |
| Representation Learning | |
| Reproducibility of research | |
| reproduction number | |
| Reproductive number | |
| resampling | |
| Residential history | |
| resilience | |
| resting state fMRI | |
| Restricted Bayes | |
| restricted mean time lost | |
| Retro-prospective | |
| retrospective cohort study | |
| Reverse causality | |
| review | |
| Ridge regression | |
| ridge regression models | |
| Right Censoring | |
| right-truncation | |
| risk classification | |
| risk difference | |
| risk factors | |
| Risk of Bias | |
| risk prediction | |
| Risk prediction models | |
| robust filtering | |
| Robust standard error | |
| robustness | |
| ROC curve | |
| Rshiny | |
| S | |
| safety | |
| sample size | |
| sample size calculation | |
| Sampling variability | |
| SAR models | |
| SARS-CoV-2 | |
| SARS-CoV-2 infection | |
| SARS-Cov2 | |
| school-based | |
| Screening | |
| Screening and surveillance | |
| Seamless design | |
| seamless phase I/II trial | |
| secondary data | |
| segmented regression | |
| SEIR | |
| SEIR model | |
| selection bias | |
| selective inference | |
| self-isolation threshold | |
| semi-competing risks | |
| Semi-Continuous | |
| semi-structured data | |
| semisupervised learning | |
| sensitivity | |
| Sensitivity analyses | |
| Sensitivity analysis | |
| separation | |
| sequential Cox approach | |
| sequential multiple assignment randomised trial | |
| SF-6D | |
| shape index | |
| Shared decision making | |
| Shrinkage | |
| simmilarities | |
| Simulation | |
| simulation analysis | |
| Simulation studies | |
| Simulation study | |
| Simulation-Extrapolation | |
| Simulations | |
| single-cells RNA-seq | |
| SIR | |
| skewed outcome | |
| Skin Neoplasms | |
| small area estimation | |
| small clinical trials | |
| small number of clusters | |
| Small sample corrections | |
| small samples | |
| socio-economic inequalities | |
| SOFA score | |
| software | |
| Software packages | |
| South Africa | |
| Sparse design | |
| spatial analysis | |
| Spatial Autocorrelation | |
| Spatial Clustering | |
| spatial effects | |
| spatiotemporal models | |
| split-mouth study | |
| spontaneous activations | |
| standard gamble | |
| standardised incidence ratio | |
| Standardization | |
| state space model | |
| Statins | |
| statistical analysis of clinical trials | |
| statistical computing | |
| statistical estimation | |
| Statistical genetics | |
| Statistical Information | |
| Statistical modelling | |
| statistical power | |
| statistical significance | |
| Statistical Software | |
| stepped wedge | |
| Stepped Wedge Design | |
| stepped wedge trials | |
| Stepped-wedge design | |
| stereotype logistic model | |
| stochastic processes | |
| stratification | |
| stratified | |
| Stratified randomisation | |
| Stroke | |
| Structural equation model | |
| Structural equation modeling | |
| study design | |
| subfertility | |
| subgroup analysis | |
| Subgroup Identification | |
| subgroup-specific treatment effects | |
| subgroups | |
| Subject-specific networks | |
| subjective psychosomatic symptoms | |
| Subpopulation selection | |
| subpopulations | |
| subsequent primary neoplasms | |
| Sufficient Follow-Up | |
| Summary genetic data | |
| Super learner | |
| superiority | |
| Supervised Machine Learning | |
| surgery | |
| Surrogacy | |
| surrogacy validation | |
| Surrogate endpoint | |
| surrogate endpoints | |
| surrogate marker | |
| surrogate outcomes | |
| survival | |
| Survival Analysis | |
| Survival data | |
| Survival data analysis | |
| survival model | |
| Survival models | |
| Survival outcomes | |
| SW-CRT | |
| synergistic and non linear association | |
| Systematic review | |
| Systematic reviews | |
| T | |
| Tailored Bayesian methods | |
| target trial | |
| target trial emulation | |
| targeted causal inference | |
| Targeted Maximum Likelihood Estimation | |
| targeted maximum likelihood estimation (TMLE) | |
| Teaching Biometry | |
| telemonitoring data | |
| temporal data | |
| Temporal relationships | |
| therapeutic threshold | |
| Three-level data | |
| threshold analysis | |
| threshold estimation | |
| time series | |
| time series analysis | |
| Time to event analysis | |
| Time trend | |
| Time-dependant confounding | |
| Time-dependent confounding | |
| time-dependent covariate | |
| time-dependent remission | |
| Time-lag bias | |
| Time-series | |
| Time-to-cure | |
| time-to-event | |
| Time-to-event analysis | |
| time-to-event data | |
| time-to-event outcome | |
| Time-to-event outcomes | |
| Time-varying confounding | |
| time-varying effect | |
| Time-varying exposures | |
| Time-varying treatment | |
| Tipping Point | |
| tolerance | |
| topological data analysis | |
| total knee replacement surgery | |
| Toxicity | |
| Toxicology | |
| Trajectories | |
| trajectory | |
| transition | |
| Transition probabilities | |
| transportability | |
| Trauma | |
| Traumatic brain injury | |
| treatment effect | |
| treatment effect heterogeneity | |
| Treatment effects | |
| Treatment rankings | |
| treatment selection marker | |
| treatment selection score | |
| treatment timing | |
| treatment-covariate interactions | |
| tree-based models | |
| tree-lasso | |
| trial | |
| trial data | |
| Trimmed means | |
| tubeless anaesthesia | |
| Tuberculosis | |
| Tuberous sclerosis complex | |
| tumor growth | |
| Tuning | |
| type I error | |
| Type M error | |
| Type S error | |
| type-I error probability | |
| type-one error | |
| U | |
| Umbrella trial | |
| Uncertainty Interval | |
| Uncertainty Measure | |
| Underreporting | |
| universal differential equations | |
| unmeasured confounding | |
| unsupervised learning | |
| Up-to-date survival predictions | |
| Updating | |
| V | |
| Vaccine | |
| Vaccines | |
| validation | |
| valvular heart disease | |
| Variable selection | |
| variance | |
| Variance estimator | |
| variance modelling | |
| variance models | |
| Variational methods | |
| varying coefficient | |
| very high CV risk | |
| Virtual biopsy | |
| W | |
| WAIC | |
| wearable devices | |
| web tool | |
| web-app | |
| Weighted analysis | |
| Weighted log-rank test | |
| weighted log-rank tests | |
| Well-defined research question | |
| Whole genome sequencing | |
| wilcoxon van elteren test | |
| Wild bootstrap | |
| within-person trial | |
| WOMAC score | |
| Women empowerment | |
| Word-embedding | |
| X | |
| Xenoestrogens | |
| Y | |
| Youden index | |
| Z | |
| Zero-inflated | |
| zero-inflation | |